+

WO2008136393A1 - Crystal of lactam compound, and method for production thereof - Google Patents

Crystal of lactam compound, and method for production thereof Download PDF

Info

Publication number
WO2008136393A1
WO2008136393A1 PCT/JP2008/058037 JP2008058037W WO2008136393A1 WO 2008136393 A1 WO2008136393 A1 WO 2008136393A1 JP 2008058037 W JP2008058037 W JP 2008058037W WO 2008136393 A1 WO2008136393 A1 WO 2008136393A1
Authority
WO
WIPO (PCT)
Prior art keywords
crystal
agent
lactam compound
production
glucose transport
Prior art date
Application number
PCT/JP2008/058037
Other languages
French (fr)
Japanese (ja)
Inventor
Shinichiro Takahashi
Yukako Sakio
Keiko Hamajima
Tatsuya Ishikawa
Junko Koizumi
Haruya Sato
Kunio Ono
Kouji Haga
Yuuji Ikegaya
Original Assignee
Ajinomoto Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2007/059540 external-priority patent/WO2008139574A1/en
Priority claimed from PCT/JP2007/059544 external-priority patent/WO2008139575A1/en
Priority claimed from PCT/JP2007/059545 external-priority patent/WO2008139576A1/en
Application filed by Ajinomoto Co., Inc. filed Critical Ajinomoto Co., Inc.
Publication of WO2008136393A1 publication Critical patent/WO2008136393A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Disclosed is a crystal of a lactam compound which has suitable levels of storage stability, easiness of handling and the like for use as an excellent medicinal agent such as a glucose transport promoting agent and a hypoglycemic agent. A crystal of a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof is useful as a medicinal agent such as a glucose transport promoting agent and a hypoglycemic agent.
PCT/JP2008/058037 2007-04-27 2008-04-25 Crystal of lactam compound, and method for production thereof WO2008136393A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/JP2007/059540 WO2008139574A1 (en) 2007-04-27 2007-04-27 Crystalline form of lactam compound and process for producing the same
PCT/JP2007/059544 WO2008139575A1 (en) 2007-04-27 2007-04-27 Preparation for oral administration
JPPCT/JP2007/059544 2007-04-27
JPPCT/JP2007/059540 2007-04-27
JPPCT/JP2007/059545 2007-04-27
PCT/JP2007/059545 WO2008139576A1 (en) 2007-04-27 2007-04-27 Method for producing lactam compound and production intermediate thereof

Publications (1)

Publication Number Publication Date
WO2008136393A1 true WO2008136393A1 (en) 2008-11-13

Family

ID=39943501

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/JP2008/058037 WO2008136393A1 (en) 2007-04-27 2008-04-25 Crystal of lactam compound, and method for production thereof
PCT/JP2008/058036 WO2008136392A1 (en) 2007-04-27 2008-04-25 Preparation for oral administration
PCT/JP2008/058038 WO2008136394A1 (en) 2007-04-27 2008-04-25 Method for production of lactam compound, and intermediate for the production method

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/JP2008/058036 WO2008136392A1 (en) 2007-04-27 2008-04-25 Preparation for oral administration
PCT/JP2008/058038 WO2008136394A1 (en) 2007-04-27 2008-04-25 Method for production of lactam compound, and intermediate for the production method

Country Status (1)

Country Link
WO (3) WO2008136393A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2011161030A1 (en) 2010-06-21 2011-12-29 Sanofi Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators
WO2012004269A1 (en) 2010-07-05 2012-01-12 Sanofi (2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals
WO2012004270A1 (en) 2010-07-05 2012-01-12 Sanofi Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament
WO2012010413A1 (en) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180282A (en) * 2009-07-02 2012-09-20 Ajinomoto Co Inc Method for producing lactam compound and production intermediate thereof
JP2012180283A (en) * 2009-07-02 2012-09-20 Ajinomoto Co Inc Method for producing lactam compound and production intermediate thereof
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP2568988B1 (en) * 2010-05-11 2016-07-13 Janssen Pharmaceutica, N.V. Pharmaceutical formulations comprising 1-(beta-d-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of sglt
EP3238723B1 (en) * 2014-12-22 2020-02-05 EA Pharma Co., Ltd. Drug for treating disorders of corneal epithelium
JP6498158B2 (en) * 2016-07-11 2019-04-10 ニプロ株式会社 Orally disintegrating tablets

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044180A1 (en) * 2000-12-01 2002-06-06 Ajinomoto Co.,Inc. Lactam compounds and medicinal use thereof
JP2003055372A (en) * 2000-05-15 2003-02-26 Takeda Chem Ind Ltd Method of production for crystal
WO2004069259A1 (en) * 2003-02-07 2004-08-19 Ajinomoto Co., Inc. Remedy for diabetes
JP2005502648A (en) * 2001-08-06 2005-01-27 レコーダチ アイルランド リミテッド Solvate of lercanidipine hydrochloride and new crystalline form of lercanidipine hydrochloride
WO2005042536A1 (en) * 2003-10-31 2005-05-12 Ajinomoto Co., Inc. Novel fused polycyclic compound having heterocycle and medicinal use thereof
WO2006039639A1 (en) * 2004-10-01 2006-04-13 Bristol-Myers Squibb Company Crystalline forms and process for preparing spiro-hydantoin compounds
WO2006118341A1 (en) * 2005-04-28 2006-11-09 Ajinomoto Co., Inc. Novel lactam compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295956B6 (en) * 1997-12-22 2005-12-14 Schering Corporation Pharmaceutical composition containing molecular dispersion
KR100882156B1 (en) * 2003-08-08 2009-02-06 아지노모토 가부시키가이샤 Nateglinide-containing formulations
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003055372A (en) * 2000-05-15 2003-02-26 Takeda Chem Ind Ltd Method of production for crystal
WO2002044180A1 (en) * 2000-12-01 2002-06-06 Ajinomoto Co.,Inc. Lactam compounds and medicinal use thereof
JP2005502648A (en) * 2001-08-06 2005-01-27 レコーダチ アイルランド リミテッド Solvate of lercanidipine hydrochloride and new crystalline form of lercanidipine hydrochloride
WO2004069259A1 (en) * 2003-02-07 2004-08-19 Ajinomoto Co., Inc. Remedy for diabetes
WO2005042536A1 (en) * 2003-10-31 2005-05-12 Ajinomoto Co., Inc. Novel fused polycyclic compound having heterocycle and medicinal use thereof
WO2006039639A1 (en) * 2004-10-01 2006-04-13 Bristol-Myers Squibb Company Crystalline forms and process for preparing spiro-hydantoin compounds
WO2006118341A1 (en) * 2005-04-28 2006-11-09 Ajinomoto Co., Inc. Novel lactam compound

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CSJ: THE CHEMICAL SOCIETY OF JAPAN: "Jikken Kagaku Guide Book", 15 June 1984, MARUZEN CO., LTD., pages: 130 - 131 *
OGATA A.: "Kagaku Jikken Sosaho", vol. 27TH ED., 20 November 1963, NANKODO CO., LTD., pages: 376 - 399 *
OKANO T.: "Shin.Yakuzaigaku Soron, revisted 3rd ed.", 10 April 1987, NANKODO CO., LTD., pages: 110 - 111 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2011161030A1 (en) 2010-06-21 2011-12-29 Sanofi Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators
WO2012004269A1 (en) 2010-07-05 2012-01-12 Sanofi (2-aryloxy-acetylamino)-phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals
WO2012004270A1 (en) 2010-07-05 2012-01-12 Sanofi Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament
WO2012010413A1 (en) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylene substituted hydroxyphenyl hexynoic acids, methods for the production thereof and use of the same as medicament
EP2567959A1 (en) 2011-09-12 2013-03-13 Sanofi 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Also Published As

Publication number Publication date
WO2008136394A1 (en) 2008-11-13
WO2008136392A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
WO2008136393A1 (en) Crystal of lactam compound, and method for production thereof
TNSN08407A1 (en) Organic compounds
WO2009054479A1 (en) Spiro-ring compound and use thereof for medical purposes
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
WO2006112549A8 (en) Fused heterocyclic compound
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2011012816A3 (en) Pharmaceutical formulation
TN2012000248A1 (en) Novel spiropiperidine compounds
WO2007003962A3 (en) Gpcr agonists
WO2007003961A3 (en) Gpcr agonists
WO2008114817A1 (en) Novel adenine compound
JO2650B1 (en) Solid Preparation
WO2009048101A1 (en) Amide compound
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
WO2009020140A1 (en) Adamantylurea derivative
EP1864665A4 (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MY174001A (en) Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
WO2008044243A3 (en) Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2007084728A3 (en) 2-imino-benzimidazoles
WO2009141718A3 (en) Process for the preparation of prostaglandin analogues and intermediates thereof
WO2008005651A3 (en) Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
WO2009153461A3 (en) Method for the synthesis of 7, 8-dimethoxy-l, 3-dihydro-2h-3-benzazepin-2-one, and the application thereof to the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid
WO2008006795A3 (en) Indole compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08752111

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08752111

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载